Carregant...
Identification and Validation of Biglycan as Prognosis and Therapy Markers for Patients with Stomach Adenocarcinoma
OBJECTIVE: Previous studies have confirmed the biglycan (BGN) as a core gene in stomach adenocarcinoma (STAD). Present study aimed at conducting further investigations to reveal the potential function of BGN in STAD. METHODS: The mRNA and protein expressions of BGN in STAD were firstly evaluated, fo...
Guardat en:
| Publicat a: | Int J Gen Med |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8290488/ https://ncbi.nlm.nih.gov/pubmed/34295178 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJGM.S321641 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|